Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • pig_raffles
    Member
    • Feb 2012
    • 23

    #1

    Strand information in DMR identification and annotation

    Hello,

    Does anyone have any information/advice on whether strand information from aligned reads is taken into account during the identification of de novo differentially methylated regions (DMRs)?

    I have used several different DMR identification software (BiSeq, DSS and eDMR) and all produce a list of candidate regions with their respective genomic coordinates but no strand information ("*"). Is the idea here that methylation within a identified DMR likely impacts regulation of genes in close proximity irrespective of strand?

    In downstream analysis this lack of strand information appears to cause issues with the annotation of DMRs. I have used the GenomicRanges package to identify gene regions that overlap with specific DMRs and then used this information in GO term enrichment analysis. However, some of the genes included as overlap hits do not seem to have any aligned CpGs, suggesting that the differentially methylated CpGs that form the overlapping DMR were located on the alternate strand.

    If this is the case, does anyone have any advice on how best to annotate DMRs where the strand information is missing to prevent these errors or maybe it is an irrelevancy?

    Thanks!

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-13-2026, 12:22 PM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-11-2026, 10:35 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
38 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
51 views
0 reactions
Last Post SEQadmin2  
Working...